Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

The importance of the QT interval: a review of the literature.

Elming H, Sonne J, Lublin HK.

Acta Psychiatr Scand. 2003 Feb;107(2):96-101. Review.

PMID:
12534434
2.

[Why is QT interval interesting?].

Elming H, Sonne J, Lublin HK.

Ugeskr Laeger. 2002 Feb 4;164(6):750-4. Review. Danish.

PMID:
11851179
3.

[Drug induced QT prolongation].

Altmann D, Eggmann U, Ammann P.

Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6. Review. German.

PMID:
18365152
4.

Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.

Wolbrette DL.

Curr Cardiol Rep. 2004 Sep;6(5):379-84. Review.

PMID:
15306095
5.

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Haddad PM, Anderson IM.

Drugs. 2002;62(11):1649-71. Review.

PMID:
12109926
6.

[Lengthening of QT interval by antipsychotic drugs].

Haverkamp W, Deuschle M.

Nervenarzt. 2006 Mar;77(3):276, 278-80, 282-4 passim. Review. German.

PMID:
16052325
7.

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.

Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG.

Cardiovasc Res. 2003 Apr 1;58(1):32-45. Review.

8.

[QTc-prolonging drugs and the risk of sudden death].

Reingardiene D, Vilcinskaite J.

Medicina (Kaunas). 2007;43(4):347-53. Review. Lithuanian.

9.

Molecular predictors of drug-induced prolongation of the QT interval.

Dilaveris PE.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Apr;3(2):105-18. Review.

PMID:
15853698
10.

[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].

Lentini S, Rao ML, Schröder R, Lüderitz B, Bauriedel G.

Dtsch Med Wochenschr. 2001 Dec 7;126(49):1396-400. German.

PMID:
11740632
11.

[Antipsychotic drugs and cardiovascular safety: need for monitoring the QT interval].

Trojak B, Pinoit JM, André D, Bonin B, Gisselmann A.

Presse Med. 2006 Apr;35(4 Pt 2):699-704. Review. French.

PMID:
16614617
12.

QT prolongation with antimicrobial agents: understanding the significance.

Owens RC Jr.

Drugs. 2004;64(10):1091-124. Review.

PMID:
15139788
13.

A case series of drug-induced long QT syndrome and Torsade de Pointes.

Tong KL, Lau YS, Teo WS.

Singapore Med J. 2001 Dec;42(12):566-70.

PMID:
11989578
14.
15.

Drug-induced QT prolongation and sudden death.

Del Rosario ME, Weachter R, Flaker GC.

Mo Med. 2010 Jan-Feb;107(1):53-8. Review.

PMID:
20222297
16.

[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].

Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V; Cardiac Safety in Schizophrenia Group.

Encephale. 2002 Nov-Dec;28(6 Pt 1):552-62. French.

PMID:
12506268
17.

QT interval prolongation, torsade de pointes and renal disease.

Patanè S, Marte F, Di Bella G, Currò A, Coglitore S.

Int J Cardiol. 2008 Nov 12;130(2):e71-3. doi: 10.1016/j.ijcard.2007.11.070. Epub 2008 Feb 5.

PMID:
18255176
18.

Drug-induced long QT and torsade de pointes: recent advances.

Kannankeril PJ, Roden DM.

Curr Opin Cardiol. 2007 Jan;22(1):39-43. Review.

PMID:
17143043
19.

Proarrhythmic potential of antimicrobial agents.

Simkó J, Csilek A, Karászi J, Lorincz I.

Infection. 2008 Jun;36(3):194-206. doi: 10.1007/s15010-007-7211-8. Epub 2008 May 3. Review.

PMID:
18454341
20.

Pharmacologic agents associated with QT interval prolongation.

Olsen KM.

J Fam Pract. 2005 Jun;Suppl:S8-S14. Review.

PMID:
15938993
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk